Point prevalence multicenter survey of antimicrobial consumption in Russian hospitals: results of the Global-PPS 2021

Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):150-158

​ Belkova Yu.А., Rachina S.А., Kozlov R.S., Kuleshov V.G., Vasilieva I.S., Kurkova A.A., Bochanova Е.N., Elokhina Е.V., Popov D.А., Portnyagina U.S., Reshetko О.V., Sychev I.N., Shegimova V.D., Drogashevskaya D.V., Chesnokova M.S., Dovgan E.V, Korolkov S.O., Kurtz E.M., Levitan A.I., Lutsevich T.S., Osokina R.A., Popova L.D., Sventitskaya E.E., Fedina L.V
10.36488/cmac.2023.2.150-158
antimicrobials hospital consumption COVID-19 quality indicators
Section
Antimicrobials
Type
Original Article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):150-158

Objective.

To evaluate prescribing patterns of antimicrobials and quantify them in relation to quality indicators in Russian multi-field hospitals.

Materials and Methods.

Point Prevalence Survey of Antimicrobial Consumption as a part of an international Global-PPS project was conducted in 8 multi-field hospitals in different Russian cities (Krasnoyarsk, Moscow, Omsk, Saratov, Smolensk, Ulan-Ude, Yakutsk) during the period from May till December 2021. Case records of patients who received therapeutic or prophylactic systemic antimicrobial agents were analyzed. Local practices of antimicrobials’ utilization were evaluated in relation to quality indicators defined by the study protocol.

Results.

Common mistakes requiring a prompt intervention included low adherence to clinical guidelines, absence of stop/review dates in the medical records, extended duration of surgical prophylaxis, III generation cephalosporin’s overuse and low rate of targeted therapy.

Conclusions.

The results of the project can be valuable for the improvement to antimicrobial utilization approaches at the study centers as well as for monitoring of antimicrobial stewardship programs’ implementation.

Yuliya А. Belkova

Smolensk State Medical University, Smolensk, Russia

Rachina S.А.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Roman S. Kozlov

Smolensk State Medical University, Smolensk, Russia

Kuleshov V.G.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Vasilieva I.S.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Anastasia A. Kurkova

Smolensk State Medical University, Smolensk, Russia

Bochanova Е.N.

Krasnoyarsk State Medical University named after prof. V.F. Voyno-Yasenetsky, Krasnoyarsk, Russia

Elokhina Е.V.

Omsk Regional Clinical Hospital, Omsk, Russia

Popov D.А.

A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia

Portnyagina U.S.

M.K. Ammosov Federal University, Yakutsk, Russia

Reshetko О.V.

Saratov State Medical University named after V.I. Razumovsky, Saratov, Russia

Igor N. Sychev

City Clinical Hospital named after S.S. Yudin, Moscow, Russia

Shegimova V.D.

Republican Clinical Hospital named after N.A. Semashko, Ulan-Ude, Russia

Drogashevskaya D.V.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Chesnokova M.S.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Dovgan E.V

Smolensk Regional Clinical Hospital, Smolensk, Russia

Korolkov S.O.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Kurtz E.M.

Regional Clinical Hospital, Krasnoyarsk, Russia

Levitan A.I.

Saratov State Medical University named after V. I. Razumovsky, Saratov, Russia

Lutsevich T.S.

Saratov State Medical University named after V. I. Razumovsky, Saratov, Russia

Osokina R.A.

A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russia

Popova L.D.

Omsk Regional Clinical Hospital, Omsk, Russia

Sventitskaya E.E.

Republican Clinical Hospital named after N.A. Semashko, Ulan-Ude, Russia

Fedina L.V

City Clinical Hospital named after S.S. Yudin, Moscow, Russia

  • 1. Calbo E., Boix-Palop L., Garau J. Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions. Curr Opin Infect Dis. 2020;33:458-463. DOI: 10.1097/QCO.0000000000000694
  • 2. Barriere S.L. Clinical, economic and societal impact of antibiotic resistance. Expert Opin Pharmacother. 2015; 16:151-153. DOI: 10.1517/14656566.2015.983077
  • 3. Global Action Plan on Antimicrobial Resistance. WHO Document Production Services, Geneva, Switzerland; 2015. Available at: www.who.int/publications/i/item/9789241509763. Accessed July 10, 2023.
  • 4. Edelstein М.V., Skleenova Е.Yu., Trushin I.V., Kuzmenkov А.Yu., Martinovich А.А., Shek Е.А., and the «CAZ-AVI-disk» Study Group. Susceptibility of clinical Enterobacterales and Pseudomonas aeruginosa isolates to ceftazidime-avibactam in Russia: multicenter local laboratory data-based surveillance. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2021;23(3): 264-278. Russian. DOI: 10.36488/cmac.2021.3.264-278
  • 5. Yakovlev S.V., Suvorova M.P., Beloborodov V.B., Basin E.E., Elisea E.V., Kovelenov S.V., et al. Prevalence and clinical significance of nosocomial infections in Russian medical institutions: ERGINI study. Antibiotiki i himioterapiya 2016;61(5-6):32-42. Russian.
  • 6. Klein E.Y., Milkowska-Shibata M., Tseng K.K., Sharland M., Gandra S., Pulcini C., et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000– 15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2020;21:107-115. DOI: 10.1016/S14733099(20)30332-7
  • 7. Sriram A., Kalanxhi E., Kapoor G., Craig J., Balasubramanian R., Brar S., et al. State of the world’s antibiotics 2021: a global analysis of antimicrobial resistance and its drivers. Center for Disease Dynamics, Economics & Policy, Washington DC; 2021. Available at: https://onehealthtrust.org/wp-content/uploads/2021/02/SOWA_01.02.2021_Low-Res.pdf. Accessed July 01, 2023.
  • 8. Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622-1629. DOI: 10.1016/j.cmi.2020.07.016
  • 9. Seaton R.A., Gibbons C.L., Cooper L., Malcolm W., McKinney R., Dundas S., et al. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. J Infect. 2020;81:952-960. DOI: 10.1016/j.jinf.2020.09.024
  • 10. Bell B.G., Schellevis F., Stobberingh, E., Goossens, H., Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13. DOI: 10.1186/14712334-14-13
  • 11. Action plan for 2019-2024 for the implementation of the Strategy for preventing the spread of antimicrobial resistance in the Russian Federation for the period up to 2030. Approved by Decree of the Government of the Russian Federation dated March 30, 2019 No. 604-r. Available at: www.garant.ru/products/ipo/prime/doc/71677266/. Russian.
  • 12. Zarb P., Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 2011;71:745755. DOI: 10.2165/11591180-000000000-00000
  • 13. New Global-PPS leaflet, English version. Available at: www.global-pps.com/wp-content/uploads/2023/03/GLOBAL-PPS-FLYER-2023-UPDATE-FINAL-1.pdf. Accessed July 10, 2023.
  • 14. Romashov O.M., Ni O.G., Bykov A.O., Kruglov A.N., Protsenko D.N., Tyurin I.N. Antimicrobial resistance and antimicrobial therapy modification during COVID-19 pandemic in large tertiary hospital. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2021;23(3):293303. Russian. DOI: 10.36488/cmac.2021.3.29330
  • 15. WHO publishes list of bacteria for which new antibiotics are urgently needed. Available at: www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-forwhich-new-antibiotics-are-urgently-needed. Accessed July 10, 2023.
  • 16. Monnier A.A., Eisenstein B.I., Hulscher M.E., Gyssens I.C., DRIVE-AB WP1 group. Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018;1:vi3-vi16. DOI: 10.1093/jac/dky114
  • 17. Hwang S., Kwon K.T. Core elements for successful implementation of antimicrobial stewardship programs. Infect Chemother. 2021;53:421-435. DOI: 10.3947/ic.2021.0093
  • 18. Ansari F., Erntell M., Goossens H., Davey P. The European surveillance of antimicrobial consumption (ESAC) pointprevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496504. DOI: 10.1086/644617
  • 19. Rachina S.A., Zakharenkov I.A., Belkova Yu.A., Vinogradova A.G., Vityazeva V.P., Domanskaya O.V., et al. Point prevalence survey of antimicrobial utilization in Russian multi-field hospitals. Klinicheskaja farmakologija i terapija. 2017;26(2):62-69. Russian.
  • 20. Rachina S., Belkova Y., Kozlov R., Versporten A., Pauwels I., Goossens H., and Russian Global-Pps project study group. Longitudinal point prevalence survey of antimicrobial consumption in Russian hospitals: results of the GlobalPPS project. Antibiotics (Basel). 2020;9(8):446. DOI: 10.3390/antibiotics9080446
  • 21. Alshaikh F.S., Godman B., Sindi O.N., Seaton R.A., Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis. PLoS One. 2022; 17(8):e0272375. DOI: 10.1371/journal.pone.0272375
  • 22. Ministry of Healthcare of Russian Federation. Temporary guidelines on COVID-19 prophylaxis, diagnostics and management. Version 17 (14 December 2022). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/061/252/original/%D0%92%D0%9C%D0%A0_COVID-19_V17.pdf. Accessed July 10, 2023. Russian.
  • 23. Living guidance for clinical management of COVID-19: Living guidance, 23 November 2021–World Health Organization (WHO). Available at: https://apps.who.int/iris/rest/bitstreams/1394399/retrieve. Accessed July 10, 2023.
  • 24. Bassetti M., Giacobbe D.R., Aliberti S., Barisione E., Centanni S., De Rosa F.G., et al.; Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020;26(7):880-894. DOI: 10.1016/j.cmi.2020.04.031
  • 25. Avdeev S., Rachina S., Belkova Y., Kozlov R., Versporten A., Pauwels I., on Behalf of Russian Global-PPS Project Study Group. Antimicrobial prescribing patterns in patients with covid-19 in Russian multi-field hospitals in 2021: results of the Global-PPS project. Trop Med Infect Dis. 2022;7(5):75. DOI: 10.3390/tropicalmed7050075
  • 26. AWaRe. Available at: https://adoptaware.org/. Accessed July 10, 2023.
  • 27. Paterson, D.L. «Сollateral damage» from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38:S341-345. DOI: 10.1086/382690
  • 28. Saurina G., Quale J.M., Manikal V.M., Oydna E., Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother. 2000;45:895898. DOI: 10.1093/jac/45.6.895
  • 29. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., Fishman N.O. Extended spectrum beta-lactamaseproducing E. coli and K. pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162-1171. DOI: 10.1086/319757
  • 30. Sukhorukova M.V., Edelstein M.V., Ivanchik N.V., Skleenova E.Yu., Shajdullina E.R., Azyzov I.S., et al. Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015-2016”. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2019;21(2):147159. Russian. DOI: 10.36488/cmac.2019.2.147-159
  • 31. Palagin I.S., Sukhorukova M.V., Dekhnich A.V., Edelstein M.V., Perepanova T.S., Kozlov R.S. and “DARMIS-2018” Study Group. Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2019;21(2):134-146. Russian. DOI: 10.36488/cmac.2019.2.134-146
  • 32. Global guidelines for the prevention of surgical site infection, second edition. Geneva: World Health Organization; 2018. Available at: www.who.int/publications/i/item/global-guidelines-for-the-prevention-of-surgical-siteinfection-2nd-ed. Accessed July 10, 2023.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared